chlorothiazide sodium
- Product NDC
- 25021-305
- 11-digit product format
- 250210305
- Labeler code
- 25021
- Product ID
- 25021-305_09b4e4be-edc0-4a5e-abb2-1572287f2abe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- chlorothiazide sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA202462
- Marketing category
- ANDA
- Marketing start
- 2019-12-15
- Substance
- CHLOROTHIAZIDE SODIUM
- Active strength
- 500 mg/18mL
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- chlorothiazide sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLOROTHIAZIDE SODIUM | 500 mg/18mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SN86FG7N2K |
| Rxcui | 484152 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25021-305-20 | chlorothiazide sodium | 18 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 18 | | 11 |
| 25021-305-20 | chlorothiazide sodium | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 11 |
| 25021-305-66 | chlorothiazide sodium | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 2 |
| 25021-305-66 | chlorothiazide sodium | 18 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 18 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| chlorothiazide sodium | ACTIVE INGREDIENT | SN86FG7N2K | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 6 | |
| chlorothiazide | ACTIVE MOIETY | 77W477J15H | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 6 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 6 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25021-305 | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 11 | Current NDC, Legacy NDC, 2 package rows | 20240910_377dc515-e381-4196-8bc7-b738606c57ac.zip |
| 25021-305 | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 2 | Current NDC, Legacy NDC, 2 package rows | 20210124_82dd0bdd-e6bd-48ea-8f58-c8bf71bbfe2c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-305-20 | 25021030520 | 1 VIAL in 1 CARTON (25021-305-20) / 18 mL in 1 VIAL | 1 vial | 2015-10-12 | 0000-00-00 | No | No | Current |
| 25021-305-66 | 25021030566 | 1 VIAL in 1 CARTON (25021-305-66) / 18 mL in 1 VIAL | 1 vial | 2019-12-15 | 0000-00-00 | No | No | Current |